|
|
4553 TOWA PHARMACEUTICAL CO.,LTD.
|
|
03/17/2025 15:30 |
Notice of Partial Revision of the Basic Policy for the Development of an Internal Control System |
02/13/2025 15:30 |
Notice of Revision of Dividend Forecasts for the Fiscal Year Ending March 31, 2025 (69th Fiscal Year) |
02/13/2025 15:30 |
Supplementary material for the financial results for the third quarter of the year ending March 31, 2025 |
02/13/2025 15:30 |
Consolidated Financial Results for the Nine Months Ended December 31, 2024 (Based on Japanese GAAP) |
01/07/2025 00:30 |
TOWA PHARMACEUTICAL INTEGRATED REPORT 2024 |
11/12/2024 15:30 |
Supplementary material for the financial results for the second quarter (interim period) of the year ending March 31, 2025 |
11/12/2024 15:30 |
Consolidated Financial Results for the Six Months Ended September 30, 2024 (Based on Japanese GAAP) |
11/05/2024 15:30 |
Notice of Revisions of Financial Forecasts |
09/30/2024 17:00 |
Notice of Settlement of Lawsuit |
08/08/2024 15:00 |
Notice of Revisions of Financial Forecasts |
08/08/2024 15:00 |
Supplementary material for the financial results for the first quarter of the year ending March 31, 2025 |
08/08/2024 15:00 |
Consolidated Financial Results for the Three Months Ended June 30, 2024 (Based on Japanese GAAP) |
07/18/2024 15:00 |
Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation |
06/25/2024 15:00 |
Matters Related to Controlling Shareholders |
06/25/2024 15:00 |
Notice of Financial Results of Parent Company, etc. |
06/25/2024 15:00 |
Notice of Disposal of Treasury Shares as Restricted Stock Compensation |
06/25/2024 15:00 |
Notice of Changes in Officers |
06/10/2024 15:00 |
Notice of Formulation of the 6th Medium-term Business Plan (2024- 2026) PROACTIVE III |
05/30/2024 08:00 |
NOTICE OF THE 68TH ORDINARY GENERAL MEETING OF SHAREHOLDERS |
05/22/2024 15:00 |
Notice of Changes in Officers |
05/14/2024 15:00 |
Supplementary material for the financial results for the year ended March 31, 2024 |
05/14/2024 15:00 |
[Summary]Summary of Consolidated Financial Results for the Year Ended March 31, 2024 (Based on Japanese GAAP) |
|